Sanofi Pasteur
174, av. de France
Paris
75013
France
Tel: 33-1-53-77-4076
Fax: 33-1-53-77-4174
Website: http://en.sanofi-aventis.com/
189 articles with Sanofi Pasteur
-
Sanofi Pasteur Delivers More H5N1 Vaccine For U.S. Government Pandemic Initiatives
2/6/2006
-
Sanofi Pasteur Experiences Unprecedented U.S. Demand For Influenza Vaccine For 2006-2007 Influenza Season
2/1/2006
-
Sanofi Pasteur To License Micro-Delivery Technology From BD Medical
12/21/2005
-
Sanofi Pasteur Announces Preliminary Trial Results For A First H5N1 Pre-Pandemic Influenza Vaccine Candidate With An Adjuvant
12/15/2005
-
Sanofi Pasteur To Complete Influenza Vaccine Shipments Ahead Of Schedule
12/1/2005
-
Aphton Corporation Announces Mutual Agreement To Dissolve Co-Promotion And Licensing Agreement Related To Anti-Cancer Product Insegia(TM) With Sanofi Pasteur
11/10/2005
-
Eisai Company, Ltd. Announces Agreement To License Novel Adjuvant From Sanofi Pasteur
10/31/2005
-
P&G, Sanofi Aventis: The U.S. Food And Drug Administration Approves Actonel(R) With Calcium
8/15/2005
-
Sanofi-Aventis Issues Strong Support for Voluntary 'Guiding Principles' on DTC Advertising
8/3/2005